BioLineRx Ltd (BLRX) — Long-term Investment Intensity

Latest as of March 2018: 1.8%

BioLineRx Ltd (BLRX) has a Long-term Investment Intensity of 1.8% as of March 2018. Long-term investments of $1.00 Million represent 1.8% of total assets of $56.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BLRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.8%
LT Investments / Total Assets

Long-term Investments

$1.00 Million
USD

Total Assets

$56.08 Million
USD

Country

USA
NASDAQ

BioLineRx Ltd Long-term Investment Intensity (2017–2017)

This chart shows how BioLineRx Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of March 2018, the intensity stands at 1.8%, reflecting long-term investments of $1.00 Million against total assets of $56.08 Million USD. For the complete balance sheet picture, see BioLineRx Ltd balance sheet assets.

Annual Long-term Investment Intensity for BioLineRx Ltd (2017–2017)

The table below presents the year-by-year Long-term Investment Intensity for BioLineRx Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BioLineRx Ltd (BLRX) total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2017 1.6% $1.00 Million $60.97 Million
pp = percentage points